C. H. ROBINSON WORLDWIDE, INC. 8-K

What Happened

• On May 29, 2026, C.H. Robinson Worldwide, Inc. announced the Talent & Compensation Committee approved a special equity award for Chief Strategy and Innovation Officer Arun Rajan. The award is valued at $7.5 million at target: $6.0M in performance stock units (PSUs) and $1.5M in restricted stock units (RSUs). The grant is made under the Amended and Restated 2022 Equity Incentive Plan and the number of units will be set by dividing the dollar value by the 30‑day average closing stock price ending the day before the grant.
• The PSUs vest based on strategic and talent development milestones over a five‑year performance period covering FY2026–FY2030, plus an “outperformance” component tied to adjusted earnings per share in 2030. The RSUs vest 20% per year over five years, with certain accelerated or continued vesting on specified terminations.

Key Details

• Total target value: $7.5 million (PSUs $6.0M; RSUs $1.5M).
• PSU components: strategic milestones = $2.5M total (two equally weighted milestones), talent development = $1.0M, outperformance tied to FY2030 adjusted EPS = $2.5M at target.
• Outperformance payout range: 50% to 200% of the outperformance target (i.e., $1.25M to $5.0M on that component).
• Forfeiture/vest rules: PSUs are forfeited if Mr. Rajan leaves for any reason other than death/disability before vesting, unless a qualifying termination occurs within 12 months after a change in control; RSUs vest 20% each year with certain accelerated/continued vesting provisions.

Why It Matters

• This award ties a senior executive’s compensation to specific strategic goals (truckload growth and AI‑enabled product adoption), talent development, and company financial performance (adjusted EPS), aligning pay with long‑term execution and shareholder value.
• The mix of PSUs and time‑vested RSUs is designed to retain Mr. Rajan through FY2030 and to reward both non‑financial strategic achievements and potential financial outperformance, which could affect future share dilution and executive compensation expense.
• Investors should note the multi‑year performance window and EPS‑linked outperformance feature when assessing potential future dilution and management incentives.